PharmacovigilanceOfficial

AEMPS updates contraceptive advice for women taking tirzepatide with oral contraceptives

🇪🇸 AEMPS · Thu 19 Nov 2026

Spain's regulator says EMA committees found limited data on tirzepatide's effect on oral contraceptives, and now advises added barrier protection or a switch to a non-oral method.

The Spanish Agency for Medicines and Medical Devices (AEMPS) published safety note MUH (FV) 04/2026 on 19 November 2026. It sets out revised contraceptive recommendations for women treated with tirzepatide, the active substance in Mounjaro.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: AEMPS ↗

Article written by VigiEye from the official source (AEMPS). AI-assisted; check the source before acting.